InsectSense, a Dutch biotech startup, secured an €800k pre-seed investment to advance its ReceptomiX technology, which objectively measures taste properties, with expectations of significant impact in the food industry.
Target Information
InsectSense is an innovative biotechnology start-up based in Wageningen, The Netherlands, specializing in the objective measurement of taste properties through its proprietary technology, ReceptomiX. Founded by Aria Samimi (CEO) and Leon Schipper (CTO), InsectSense has developed an advanced system that employs a biochip containing human and insect receptors, coupled with a benchtop device and software to accurately read and interpret taste-related data.
The ReceptomiX technology provides a crucial advancement in the food industry by enabling rapid and objective analysis of the bioactivity of various molecules and compounds concerning human taste and health effects. This technology offers an alternative to traditional methods which often depend on subjective evaluations from human panels, addressing a significant gap in food flavor assessment.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in The Netherlands
The Netherlands boasts a robust and innovative food technology sector, recognized for its commitment to addressing global challenges, including food sustainability and health. Th
Similar Deals
Capricorn Partners, Oost NL, Angel Investor → InsectSense
2023
NLC Health Ventures → NeurOdys Therapeutics
Lead Ventures, J&T Ventures → XUND
2025
Capricorn Partners, Oost NL and an angel investor
invested in
InsectSense
in
in a Pre-Seed Stage deal
Disclosed details
Transaction Size: $1M